Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

SIRP-α3 Inhibitors

SIRP-α3 inhibitors are a class of chemical compounds designed to specifically target and block the activity of the Signal Regulatory Protein Alpha 3 (SIRP-α3), a member of the immunoglobulin superfamily. SIRP-α3, like other SIRP family members, is expressed on the surface of myeloid cells such as macrophages, dendritic cells, and neutrophils, playing a significant role in regulating immune cell signaling and function. Through its interactions with ligands, such as CD47, SIRP-α3 transmits inhibitory signals that modulate immune responses, including suppression of phagocytosis, cell adhesion, and migration. By inhibiting SIRP-α3, researchers can disrupt these signaling pathways, allowing them to better understand the role of this protein in immune regulation and cell communication.

SIRP-α3 inhibitors serve as important tools for studying the molecular pathways involved in immune cell activity, especially in processes like cell-cell communication and the immune response. By blocking the function of SIRP-α3, researchers can observe how immune cells' behavior changes, particularly in relation to their ability to engage in phagocytosis and other immune functions. This inhibition allows scientists to explore how SIRP-α3 interacts with other immune receptors and signaling molecules, providing insights into the larger networks that control immune cell behavior and homeostasis. The use of SIRP-α3 inhibitors contributes to a deeper understanding of how inhibitory signaling regulates the immune system, shedding light on the balance between activation and suppression of immune responses. These studies enhance knowledge about the regulation of immune cell functions and their impact on various biological processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine may downregulate SIRP-α3 by inducing demethylation of its gene promoter, leading to a suppressed transcriptional initiation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A could decrease SIRP-α3 levels by inhibiting histone deacetylase, resulting in a less condensed chromatin state that represses gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Suberoylanilide Hydroxamic Acid might lead to a reduction in SIRP-α3 synthesis by altering the acetylation pattern of histones near the SIRP-α3 gene, thereby hindering mRNA production.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

RG 108 potentially inhibits SIRP-α3 expression by blocking DNA methyltransferases, which could prevent the methylation-mediated silencing of the gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

Mithramycin A can bind to specific DNA sequences upstream of the SIRP-α3 gene, possibly obstructing the binding of transcriptional activators and thus decreasing gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

5-Aza-2′-Deoxycytidine could downregulate SIRP-α3 by reducing DNA methylation levels, thereby diminishing the recruitment of transcriptional repressors to the gene locus.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D has the potential to inhibit SIRP-α3 expression by intercalating into DNA and obstructing the elongation phase of transcription by RNA polymerase.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Cyclopamine may decrease SIRP-α3 protein levels by inhibiting the Hedgehog signaling pathway, which might be necessary for the gene's expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin could inhibit the expression of SIRP-α3 by downregulating mTOR signaling, which may be crucial for the synthesis of this protein.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 might reduce SIRP-α3 expression by inhibiting the PI3K/Akt pathway, which can govern the transcription of various genes.